Obesity and COPD: Associated Symptoms, Health-related Quality of Life, and Medication Use
- 2 August 2011
- journal article
- research article
- Published by Taylor & Francis Ltd in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 8 (4), 275-284
- https://doi.org/10.3109/15412555.2011.586660
Abstract
Background: There is little data about the combined effects of COPD and obesity. We compared dyspnea, health-related quality of life (HRQoL), exacerbations, and inhaled medication use among patients who are overweight and obese to those of normal weight with COPD. Methods: We performed secondary data analysis on 364 Veterans with COPD. We categorized subjects by body mass index (BMI). We assessed dyspnea using the Medical Research Council (MRC) dyspnea scale and HRQoL using the St. George's Respiratory Questionnaire. We identified treatment for an exacerbation and inhaled medication use in the past year. We used multiple logistic and linear regression models as appropriate, with adjustment for age, COPD severity, smoking status, and co-morbidities. Results: The majority of our population was male (n = 355, 98%) and either overweight (n = 115, 32%) or obese (n = 138, 38%). Obese and overweight subjects had better lung function (obese: mean FEV1 55.4% ±19.9% predicted, overweight: mean FEV1 50.0% ±20.4% predicted) than normal weight subjects (mean FEV1 44.2% ±19.4% predicted), yet obese subjects reported increased dyspnea [adjusted OR of MRC score ≥2 = 4.91 (95% CI 1.80, 13.39], poorer HRQoL, and were prescribed more inhaled medications than normal weight subjects. There was no difference in any outcome between overweight and normal weight patients. Conclusions: Despite having less severe lung disease, obese patients reported increased dyspnea and poorer HRQoL than normal weight patients. The greater number of inhaled medications prescribed for obese patients may represent overuse. Obese patients with COPD likely need alternative strategies for symptom control in addition to those currently recommended.Keywords
This publication has 37 references indexed in Scilit:
- Combined Effects of Obesity and Chronic Obstructive Pulmonary Disease on Dyspnea and Exercise ToleranceAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study resultsEuropean Respiratory Journal, 2009
- The influence of obesity on pulmonary rehabilitation outcomes in patients with COPDChronic Respiratory Disease, 2008
- Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary DiseaseJAMA, 2008
- Obesity and the lung: 5 {middle dot} Obesity and COPDThorax, 2008
- Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary originsBritish Journal of Nutrition, 2008
- Prevalence of Overweight and Obesity in the United States, 1999-2004JAMA, 2006
- Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 2003
- Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax, 1999
- Best Subsets Logistic RegressionBiometrics, 1989